• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经颈静脉肝内门体分流术后使用部分脾栓塞术以减轻持续性门静脉高压后遗症

Use of Partial Splenic Embolization Following a Transjugular Intrahepatic Portosystemic Shunt to Reduce Persistent Portal Hypertension Sequelae.

作者信息

Schultz Gunnar, Naas Mohamed, Webb Jay

机构信息

Radiology, Florida State University College of Medicine, Pensacola, USA.

Radiology, Florida State University College of Medicine, Tallahassee, USA.

出版信息

Cureus. 2025 Aug 7;17(8):e89540. doi: 10.7759/cureus.89540. eCollection 2025 Aug.

DOI:10.7759/cureus.89540
PMID:40918905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12413769/
Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) placement is a well-established intervention for portal hypertension. However, some patients experience persistent complications such as encephalopathy, ascites, or thrombocytopenia, especially when further TIPS optimization is not technically possible. Partial splenic embolization (PSE), typically performed for hypersplenism or certain hematologic conditions, can reduce portal venous inflow and improve cytopenias; however, its use as an adjunct to TIPS is less well described. We present the case of a 73-year-old male with cirrhosis secondary to hepatitis C who developed recurrent ascites, worsening encephalopathy, and refractory thrombocytopenia following portal vein recanalization with TIPS placement 18 months prior. The patient's TIPS could not be further optimized due to technical limitations. Imaging demonstrated marked splenomegaly and an enlarged splenic artery, suggesting increased splenic contribution to portal inflow. PSE of the lower pole was performed. Post-procedure, the patient experienced significant clinical improvement. Encephalopathy episodes resolved, no ascites was seen on follow-up CT, and platelet count rose from <50,000/µL to >100,000//µL. The patient subsequently developed a splenic abscess requiring percutaneous intervention. PSE may serve as an effective adjuvant to TIPS in selected patients with persistent portal hypertension and cytopenias when further TIPS optimization is not possible. This case highlights the potential for PSE to reduce portal inflow and improve platelet count, suggesting an expanded role in the management of complex portal hypertension.

摘要

经颈静脉肝内门体分流术(TIPS)置入是一种成熟的门静脉高压治疗手段。然而,部分患者会出现诸如肝性脑病、腹水或血小板减少等持续性并发症,尤其是在技术上无法进一步优化TIPS时。部分脾栓塞术(PSE)通常用于治疗脾功能亢进或某些血液系统疾病,可减少门静脉血流并改善血细胞减少症;然而,其作为TIPS辅助治疗的应用描述较少。我们报告一例73岁男性患者,其因丙型肝炎继发肝硬化,在18个月前接受TIPS置入门静脉再通术后出现反复腹水、肝性脑病加重及难治性血小板减少症。由于技术限制,该患者的TIPS无法进一步优化。影像学检查显示脾脏明显肿大及脾动脉增粗,提示脾脏对门静脉血流的贡献增加。遂对脾下极进行了PSE。术后,患者临床症状显著改善。肝性脑病发作缓解,随访CT未见腹水,血小板计数从<50,000/µL升至>100,000/µL。该患者随后出现脾脓肿,需要进行经皮介入治疗。对于部分无法进一步优化TIPS的持续性门静脉高压和血细胞减少症患者,PSE可作为一种有效的TIPS辅助治疗方法。该病例突出了PSE减少门静脉血流和提高血小板计数的潜力,提示其在复杂门静脉高压管理中的作用可能扩大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa6/12413769/46de880e3157/cureus-0017-00000089540-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa6/12413769/23a939b7b82f/cureus-0017-00000089540-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa6/12413769/96a5a91a1669/cureus-0017-00000089540-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa6/12413769/6a627b61cfec/cureus-0017-00000089540-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa6/12413769/46de880e3157/cureus-0017-00000089540-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa6/12413769/23a939b7b82f/cureus-0017-00000089540-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa6/12413769/96a5a91a1669/cureus-0017-00000089540-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa6/12413769/6a627b61cfec/cureus-0017-00000089540-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/daa6/12413769/46de880e3157/cureus-0017-00000089540-i04.jpg

相似文献

1
Use of Partial Splenic Embolization Following a Transjugular Intrahepatic Portosystemic Shunt to Reduce Persistent Portal Hypertension Sequelae.经颈静脉肝内门体分流术后使用部分脾栓塞术以减轻持续性门静脉高压后遗症
Cureus. 2025 Aug 7;17(8):e89540. doi: 10.7759/cureus.89540. eCollection 2025 Aug.
2
Lines of Zahn in a Patient With Transjugular Intrahepatic Portosystemic Shunt Occlusion From a Tumor Thrombus: A Case Report.经颈静脉肝内门体分流术因肿瘤血栓形成闭塞患者的扎恩线:病例报告
Cureus. 2025 Jul 15;17(7):e88011. doi: 10.7759/cureus.88011. eCollection 2025 Jul.
3
Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.聚四氟乙烯覆膜支架与裸支架经颈静脉肝内门体分流术治疗肝硬化的效果比较。
Cochrane Database Syst Rev. 2023 Aug 2;8(8):CD012358. doi: 10.1002/14651858.CD012358.pub2.
4
Sarcopenia is a risk factor for post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy and mortality: A systematic review and meta-analysis.肌肉减少症是经颈静脉肝内门体分流术肝性脑病和死亡率的一个风险因素:系统评价和荟萃分析。
Indian J Gastroenterol. 2024 Aug;43(4):748-759. doi: 10.1007/s12664-023-01465-2. Epub 2023 Dec 12.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis.TIPS 通过个体患者数据分析荟萃分析预防肝硬化和门静脉高压患者的进一步失代偿并改善生存。
J Hepatol. 2023 Sep;79(3):692-703. doi: 10.1016/j.jhep.2023.04.028. Epub 2023 May 2.
7
Efficacy and safety of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma-A systematic review and meta-analysis.经颈静脉肝内门体分流术治疗肝细胞癌的疗效和安全性:系统评价和荟萃分析。
Indian J Gastroenterol. 2024 Dec;43(6):1121-1135. doi: 10.1007/s12664-024-01646-7. Epub 2024 Aug 10.
8
Identifying the optimal measurement timing and hemodynamic targets of portal pressure gradient after TIPS in patients with cirrhosis and variceal bleeding.确定肝硬化合并静脉曲张出血患者经颈静脉肝内门体分流术后门静脉压力梯度的最佳测量时机和血流动力学目标。
J Hepatol. 2025 Feb;82(2):245-257. doi: 10.1016/j.jhep.2024.08.007. Epub 2024 Aug 22.
9
Feasibility, Safety and Efficacy of Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis.经颈静脉肝内门体分流术治疗肝硬化门静脉血栓形成的可行性、安全性及疗效
J Clin Exp Hepatol. 2025 Sep-Oct;15(5):102580. doi: 10.1016/j.jceh.2025.102580. Epub 2025 Apr 12.
10
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Nutrition in Liver Cirrhosis Patients: A Systematic Review.经颈静脉肝内门体分流术对肝硬化患者营养状况的影响:系统评价。
Nutrients. 2023 Mar 27;15(7):1617. doi: 10.3390/nu15071617.

本文引用的文献

1
Recurrent TIPS dysfunction and variceal bleeding: A combined, staged, use of large-bore aspiration thrombectomy and partial splenic artery embolization-A case report.复发性经颈静脉肝内门体分流术功能障碍与静脉曲张出血:大口径抽吸血栓切除术与部分脾动脉栓塞术联合分期应用——病例报告
Radiol Case Rep. 2024 Oct 30;20(1):352-356. doi: 10.1016/j.radcr.2024.10.003. eCollection 2025 Jan.
2
Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure.肝硬化的病理生理学与管理:从门静脉高压到慢加急性肝衰竭
Front Med (Lausanne). 2023 Jun 15;10:1060073. doi: 10.3389/fmed.2023.1060073. eCollection 2023.
3
Partial splenic embolization as a rescue and emergency treatment for portal hypertension and gastroesophageal variceal hemorrhage.
部分性脾栓塞术作为门静脉高压和胃食管静脉曲张出血的抢救和急症治疗。
BMC Gastroenterol. 2023 May 24;23(1):180. doi: 10.1186/s12876-023-02808-1.
4
Hepatic Encephalopathy After TIPS Placement: Predictive Factors, Prevention Strategies, and Management.经颈静脉肝内门体分流术(TIPS)置入术后的肝性脑病:预测因素、预防策略及管理
Cardiovasc Intervent Radiol. 2022 May;45(5):570-577. doi: 10.1007/s00270-021-03045-3. Epub 2022 Jan 3.
5
Shunt-Induced Hepatic Encephalopathy in TIPS: Current Approaches and Clinical Challenges.经颈静脉肝内门体分流术(TIPS)相关的分流性肝性脑病:当前治疗方法与临床挑战
J Clin Med. 2020 Nov 23;9(11):3784. doi: 10.3390/jcm9113784.
6
Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.肝硬化患者经颈静脉肝内门体分流术:详尽的批判性更新。
World J Gastroenterol. 2020 Oct 7;26(37):5561-5596. doi: 10.3748/wjg.v26.i37.5561.
7
Hepatic encephalopathy: a critical current review.肝性脑病:关键性综述
Hepatol Int. 2018 Feb;12(Suppl 1):135-147. doi: 10.1007/s12072-017-9812-3. Epub 2017 Aug 2.
8
An Overview of Splenic Embolization.脾脏栓塞术概述。
AJR Am J Roentgenol. 2015 Oct;205(4):720-5. doi: 10.2214/AJR.15.14637.
9
Transjugular intrahepatic portosystemic shunt complications: prevention and management.经颈静脉肝内门体分流术并发症:预防与处理
Semin Intervent Radiol. 2015 Jun;32(2):123-32. doi: 10.1055/s-0035-1549376.
10
Clinical application of partial splenic embolization.部分脾栓塞术的临床应用
ScientificWorldJournal. 2014;2014:961345. doi: 10.1155/2014/961345. Epub 2014 Nov 3.